article thumbnail

DEA Extends COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for 6 Months

HIT Consultant

Background On March 1, 2023, DEA, in concert with HHS, issued notices of proposed rulemakings (NPRM) to allow for prescribing of certain controlled medications via telemedicine without an in-person medical evaluation of the patient under circumstances that are consistent with public health, safety, and effective controls against diversion.

article thumbnail

Five Public Health Needs for Digital Health Technology

The Digital Health Corner

Digital health technology has seen an incredible growth in the last few years, fueled by a combination of consumerization of wearable technologies, ubiquity of mobile devices, proliferation of technology incubators, attention by government health and regulatory agencies and involvement of large companies heretofore not focused on healthcare.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

DEA officially extends remote EPCS flexibilities for 6 months

Healthcare IT News - Telehealth

Department of Health and Human Services said it would temporarily extend telemedicine flexibilities for the prescription of certain controlled medications granted under the COVID-19 Public Health Emergency, which is set to expire on May 11.

article thumbnail

Prior Authorization Insurance Requirements: A Barrier to Accessing Lifesaving Treatment for Opioid Use Disorder?

Bill of Health

For example, prescribers of buprenorphine must obtain a waiver from the Substance Abuse and Mental Health Services Administration (SAMHSA) prior to writing prescriptions to treat OUD, and those practitioners who wish to treat more than 30 patients are mandated to undertake training. appeared first on Bill of Health.

Medicaid 246
article thumbnail

Tele-Prescribing Flexibilities Extended Again in Second Temporary Rule

Healthcare Law Blog

Some concerns and reasons noted by the DEA for extending the telemedicine flexibilities include: Reductions in access to care for patients who may not have an established practitioner-patient relationship; Practitioner backlogs for providing in-person medical evaluations; and Urgent public health needs for certain controlled medications.

article thumbnail

Comprehensive Guide to Medication-Assisted Treatment (MAT) Billing

Medisys Compliance

Ultimately, accurate billing not only ensures fair compensation for services rendered but also underpins the sustained provision of life-saving MAT interventions, embodying the pivotal role of billing proficiency in advancing public health initiatives. Looking to streamline your billing process?

article thumbnail

Senate Committee’s PREVENT Pandemics Act Draft Released: What to Know

Healthcare Law Today

It also requires that the Secretary report to Congress on the state of the SNS, and to issue guidance and hold annual meetings with public health officials and stakeholders on how states, territories, and Tribes can access the SNS. Modernizes public health data through biosurveillance and infectious disease data collection.